| Title | Guidance: Bioavailability Studies Submitted in New Drug Applications or Investigational New Drug Applications--General Considerations |
| ToC Doc | Bioavailability Studies Submitted in New Drug Applications or Investigational New Drug Applications--General Considerations |
| Docket Number | 2022-08114 |
| Type | Notice |
| Subject | Guidance: Bioavailability Studies Submitted in New Drug Applications or Investigational New Drug Applications--General Considerations |
| Publication Date | 2022-04-15 |
| Last Updated Date | 2022-04-14 08:15:12 -0400 |
| Last Public Inspection | 2022-04-14 |
| Filed At | 2022-04-14T08:45:00.000-04:00 |
| 2022-08114_PI.pdf (107352 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 6 |
| Filing Type | regular |
| Agencies | Food and Drug Administration |
You can find the raw source document below...